Zimmer Biomet Holdings, Inc. (ZBH) financial statements and ratios from SEC XBRL: revenue $8.23B (TTM), net margin 8.6%, revenue growth 9.3% YoY, P/E 25.2. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $8.23B |
| Net Margin | 8.6% |
| Revenue Growth (YoY) | 9.3% |
| EPS Growth (YoY) | 32.6% |
| FCF Growth (YoY) | -4.5% |
| P/E Ratio | 25.2 |
| EV / EBITDA | 11.4 |
| Price / Book | 1.51 |
| Price / Sales | 2.28 |
| FCF Yield | 7.6% |
| DCF Value (model) | $4.27 |
| DCF Upside vs Price | -95.7% |
| Altman Z-Score | 2.47 (grey) |
| Piotroski F-Score | 5/9 |
| Sector P/E (Healthcare) | 21.6 |
ZBH overview · ZBH earnings · ZBH KPIs · ZBH investor relations · ZBH ownership · ZBH peers · ZBH filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.